- Home
- NATR vs SERA Comparison
NATR vs SERA Comparison
Compare NATR & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NATR | SERA |
|---|---|---|
| Founded | 1972 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precision Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.4M | 130.5M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NATR | SERA |
|---|---|---|
| Price | $22.54 | $3.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $21.33 | N/A |
| AVG Volume (30 Days) | ★ 109.6K | 51.5K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.80 | N/A |
| Revenue | ★ $474,542,000.00 | $95,000.00 |
| Revenue This Year | $7.30 | $19.22 |
| Revenue Next Year | $3.44 | $400.00 |
| P/E Ratio | $27.82 | ★ N/A |
| Revenue Growth | ★ 6.62 | 1.06 |
| 52 Week Low | $11.01 | $1.37 |
| 52 Week High | $24.12 | $9.13 |
Technical Indicators
Market Signals| Indicator | NATR | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 64.84 | 59.96 |
| Support Level | $21.63 | $3.20 |
| Resistance Level | $24.12 | $3.72 |
| Average True Range (ATR) | 0.92 | 0.27 |
| MACD | -0.07 | 0.05 |
| Stochastic Oscillator | 58.33 | 82.43 |
Price Performance
Historical ComparisonAbout NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.